Jiping Tang Selected Research

Interleukins

11/2021	Enhanced IL-10 inhibits proliferation and promotes apoptosis of HUVECs through STAT3 signaling pathway in sepsis.
5/2015	Receptor for advanced glycation end-product antagonist reduces blood-brain barrier damage after intracerebral hemorrhage.
2/2014	Isoflurane on brain inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiping Tang Research Topics

Disease

104	Brain Injuries (Brain Injury) 11/2023 - 06/2004
82	Brain Edema (Cerebral Edema) 01/2023 - 10/2004
60	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 05/2024 - 05/2006
55	Cerebral Hemorrhage 12/2022 - 10/2004
47	Hypoxia (Hypoxemia) 01/2022 - 08/2005
39	Inflammation (Inflammations) 11/2023 - 06/2008
37	Neuroinflammatory Diseases 03/2024 - 12/2012
37	Stroke (Strokes) 02/2024 - 05/2009
35	Hemorrhage 02/2024 - 07/2002
30	Infarction (Infarctions) 12/2023 - 05/2009
29	Ischemia 01/2021 - 08/2005
22	Hematoma 02/2024 - 01/2011
22	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2024 - 07/2010
20	Ischemic Stroke 01/2023 - 05/2007
16	Brain Infarction 12/2023 - 09/2011
12	Atrophy 01/2021 - 11/2009
11	Brain Ischemia (Cerebral Ischemia) 01/2024 - 06/2004
9	Hyperglycemia 10/2021 - 06/2011
8	Wounds and Injuries (Trauma) 01/2018 - 03/2007
7	Edema (Dropsy) 12/2020 - 12/2011
7	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 05/2020 - 02/2010
7	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 02/2014
6	Hydrocephalus (Hydrocephaly) 02/2022 - 07/2012
6	Body Weight (Weight, Body) 10/2016 - 01/2008
4	Hemorrhagic Stroke 01/2018 - 03/2010
4	Neurologic Manifestations (Neurological Manifestations) 08/2015 - 10/2004
3	Thrombosis (Thrombus) 02/2024 - 01/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2017
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 06/2015
3	Encephalitis (Encephalitis, Rasmussen) 10/2020 - 02/2014
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019 - 01/2018
3	Nervous System Diseases (Neurological Disorders) 06/2018 - 01/2015
3	Rupture 01/2018 - 01/2011

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2005
21	Neuroprotective AgentsIBA 01/2024 - 03/2009
21	salicylhydroxamic acid (SHAM)IBA 01/2019 - 03/2005
19	Small Interfering RNA (siRNA)IBA 01/2021 - 12/2012
19	Oxygen (Dioxygen)IBA 01/2018 - 05/2006
18	Collagenases (Collagenase)FDA Link 01/2024 - 10/2004
16	Hemoglobins (Hemoglobin)IBA 01/2024 - 02/2011
13	Caspase 3 (Caspase-3)IBA 01/2021 - 04/2008
12	OsteopontinIBA 03/2024 - 02/2011
12	Isoflurane FDA LinkGeneric 10/2020 - 07/2010
11	fluoro-jade CIBA 12/2023 - 04/2017
10	CytokinesIBA 11/2023 - 02/2014
10	Evans Blue (Blue, Evans)FDA Link 07/2017 - 04/2008
10	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 06/2011
9	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2015 - 05/2007
8	CateninsIBA 09/2021 - 04/2012
8	HydrogenIBA 01/2021 - 01/2011
8	Anesthetics (Anesthetic Agents)IBA 10/2020 - 07/2010
7	InflammasomesIBA 03/2024 - 10/2013
7	AntioxidantsIBA 01/2024 - 03/2010
7	Tight Junction ProteinsIBA 01/2024 - 11/2009
7	Sirtuin 1IBA 10/2021 - 02/2015
6	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2024 - 10/2019
6	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 09/2013
6	Protein Kinases (Protein Kinase)IBA 01/2021 - 01/2016
6	Peroxidase (Myeloperoxidase)IBA 01/2018 - 06/2008
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2023 - 01/2018
5	EnzymesIBA 01/2023 - 06/2011
5	Immunoglobulin G (IgG)IBA 01/2021 - 04/2008
5	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 11/2009
5	Adenosine Monophosphate (AMP)IBA 10/2020 - 04/2017
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016 - 02/2010
5	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2007 - 06/2004
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 06/2008
4	Glycoproteins (Glycoprotein)IBA 01/2023 - 10/2014
4	LigandsIBA 01/2022 - 10/2020
4	Thrombin FDA Link 01/2021 - 12/2011
4	IntegrinsIBA 01/2021 - 12/2014
4	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2021 - 10/2004
4	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 01/2015
4	Phosphotransferases (Kinase)IBA 01/2019 - 05/2013
4	Blood Glucose (Blood Sugar)IBA 07/2018 - 06/2011
4	p38 Mitogen-Activated Protein KinasesIBA 04/2018 - 12/2013
4	TOR Serine-Threonine KinasesIBA 04/2017 - 07/2012
4	Coloring Agents (Dyes)IBA 01/2016 - 02/2011
4	Erythropoietin FDA Link 01/2015 - 10/2011
3	6alpha-ethyl-23(S)-methylcholic acidIBA 03/2024 - 11/2019
3	Scavenger Receptors (Scavenger Receptor)IBA 02/2024 - 01/2018
3	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 11/2023 - 01/2018
3	ImmunosorbentsIBA 01/2023 - 02/2014
3	CC ChemokinesIBA 01/2022 - 03/2021
3	Dinoprostone (PGE2)FDA Link 01/2022 - 01/2011
3	BMS-470539IBA 01/2022 - 01/2020
3	NucleotidesIBA 12/2021 - 01/2018
3	InterleukinsIBA 11/2021 - 02/2014
3	Adenosine Triphosphate (ATP)IBA 10/2021 - 05/2009
3	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 10/2021 - 10/2020
3	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 03/2021 - 10/2014
3	NF-kappa B (NF-kB)IBA 01/2021 - 02/2015
3	Messenger RNA (mRNA)IBA 01/2019 - 06/2004
3	Heme (Haem)IBA 12/2018 - 04/2017
3	Netrin-1IBA 01/2018 - 01/2017

Therapy/Procedure

31	Therapeutics 01/2023 - 01/2011
31	Ligation 01/2022 - 09/2008
10	Intranasal Administration 12/2023 - 01/2016
10	Neurosurgical Procedures 01/2020 - 03/2007
8	Hyperbaric Oxygenation 04/2016 - 01/2008